[Effects of benazepril combined with valsartan on congestive heart failure]
- PMID: 16305977
[Effects of benazepril combined with valsartan on congestive heart failure]
Abstract
Objective: To observe the effects of routine doses of benazepril combined with valsartan on congestive heart failure.
Methods: Totally 203 patients with congestive heart failure were randomized into Group A (receiving benazepril 20 mg/day), Group B (benazepril,10 mg/day plus valsartan, 80 mg/day), and group C (valsartan 160 mg/day) for different treatment protocols on the basis of routine therapy for heart failure with digitalis, diuretics and beta blockers. The cardiac functions and echocardiographical findings were evaluated before and after the treatments.
Results: All the patients showed improvement of NYHA class, left ventricular end-diastolic dimension (LVEDd), left ventricular end-systolic dimension (LVESd) and left ventricular ejection fraction (LVEF) (P<0.01), and the effect was better in group B than in group A (P>0.05), and both groups A and B had better results than group C (P<0.05). No serious adverse effects were found.
Conclusion: The combination of benazepril and valsartan at routine doses can be effective for treating congestive heart failure.
Similar articles
-
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).Circulation. 2005 Nov 29;112(22):3391-9. doi: 10.1161/CIRCULATIONAHA.105.551143. Epub 2005 Nov 21. Circulation. 2005. PMID: 16301343 Clinical Trial.
-
Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.J Nucl Med. 2003 Jun;44(6):884-90. J Nucl Med. 2003. PMID: 12791814 Clinical Trial.
-
Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.Clin Pharmacol Ther. 2010 Jun;87(6):686-92. doi: 10.1038/clpt.2010.36. Epub 2010 May 5. Clin Pharmacol Ther. 2010. PMID: 20445533 Clinical Trial.
-
Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Adv Ther. 2008. PMID: 18449492 Review.
-
[Treatment of congestive heart failure].Tidsskr Nor Laegeforen. 2007 Jan 18;127(2):174-7. Tidsskr Nor Laegeforen. 2007. PMID: 17237864 Review. Norwegian.
Cited by
-
Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.Biosci Rep. 2018 May 22;38(3):BSR20171036. doi: 10.1042/BSR20171036. Print 2018 May 29. Biosci Rep. 2018. PMID: 29301869 Free PMC article.
-
Angiotensin receptor blockers for heart failure.Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD003040. doi: 10.1002/14651858.CD003040.pub2. Cochrane Database Syst Rev. 2012. PMID: 22513909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical